Medtronic plc (FRA:2M6)
| Market Cap | 107.91B |
| Revenue (ttm) | 29.88B |
| Net Income (ttm) | 4.10B |
| Shares Out | n/a |
| EPS (ttm) | 3.17 |
| PE Ratio | 26.35 |
| Forward PE | 16.80 |
| Dividend | 2.54 (3.01%) |
| Ex-Dividend Date | Sep 26, 2025 |
| Volume | 170 |
| Average Volume | 724 |
| Open | 84.02 |
| Previous Close | 84.04 |
| Day's Range | 83.81 - 84.45 |
| 52-Week Range | 68.50 - 91.45 |
| Beta | n/a |
| RSI | 44.78 |
| Earnings Date | Feb 17, 2026 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]
Financial Performance
In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial numbers in USD Financial StatementsNews
Medtronic: Will a Robot Help Perform Your Next Surgery?
FDA clears the Medtronic Hugo robotic-assisted surgery system for urologic procedures. NORTHAMPTON, MA / ACCESS Newswire / December 15, 2025 / James Choate-Deeds and his wife Caryn held hands and b...
Dividend Income: Lanny's October 2025 Summary
In October, we (my wife and I) received a dividend income total of $3,948.78. Crushing it for an off-month – thanks to Vanguard (VOO) and Fidelity (FXAIX) for paying in October. We had quite a few div...
This Dividend Stock Just Hit a Major Milestone. Time to Buy?
Medtronic earned regulatory clearance in the U.S. for its Hugo robotic-assisted surgery system. This device will take time to have a material impact on the company's financial results.
3 Dividend Stocks to Hold for the Next 10 Years
If you are looking for dividend stocks that you can buy and hold, consider UPS, General Mills, and Medtronic.
Hot Picks: Large-cap health care stocks to watch for dividend growth
Portfolio manager highlights AbbVie, Pfizer and Medtronic as compelling large-cap health care dividend plays with growth and valuation support.
Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors
Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that Sean Salmo...
Medtronic: This Dividend Aristocrat Is Just Getting Started
3 No-Brainer Dividend Stocks to Buy Right Now
Enterprise Products Partners will produce significantly more free cash flow in 2026. Medtronic is only two years away from achieving a rare dividend milestone.
Forget Medtronic, Buy This Healthcare Stock Instead
That is, if you can handle more volatility.
Medtronic (MDT) Upgraded to Buy: Here's Why
Medtronic (MDT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Medtronic (MDT) Maintains Quarterly Dividend of $0.71 Per Share
Medtronic (MDT) Maintains Quarterly Dividend of $0.71 Per Share
Medtronic announces cash dividend for third quarter of fiscal year 2026
GALWAY, Ireland , Dec. 4, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 4, 2025, approved the company's cash dividend for the third quarter of fiscal y...
Medtronic Scores FDA Win As Hugo Surgical Robot Enters 230,000 Urology Procedure Market
On Wednesday, the U.S. Food and Drug Administration (FDA) cleared Medtronic Plc’s (NYSE: MDT) Hugo robotic-assisted surgery (RAS) system for use in urologic surgical procedures . MDT is in positive t...
Prediction: 1 Healthcare Giant Set to Soar in 2026
Medtronic recently delivered strong quarterly results thanks to a fast-growing franchise. This tailwind, along with others, could help maintain the stock's momentum into 2026.
FDA Clears Medtronic's Hugo Robotic-Assisted Surgery System For Urologic Procedures
(RTTNews) - Medtronic (MDT) announced that it has received FDA clearance for its Hugo robotic-assisted surgery (RAS) system in urologic procedures, marking a significant milestone in its surgical inno...
Medtronic (MDT) Gains FDA Approval for Hugo Robotic Surgery System
Medtronic (MDT) Gains FDA Approval for Hugo Robotic Surgery System
Medtronic (MDT) Secures FDA Approval for Hugo Robotic Surgery System
Medtronic (MDT) Secures FDA Approval for Hugo Robotic Surgery System
Medtronic gets FDA clearance of Hugo robotic-assisted surgery system
Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures
Hugo RAS system brings choice to the U.S., coupled with the full suite of Medtronic surgical offerings, ultimately creating a connected and integrated operating room today and into the future. GALWAY,...
The US Rollout of MiniMed 780G With Abbott's Sensor May Lift MDT Stock
Medtronic begins the U.S. rollout of MiniMed 780G with Abbott's Instinct sensor, advancing diabetes care.
Medtronic Launches MiniMed 780G In U.S. With Abbott's New Instinct CGM Sensor
DUBLIN (dpa-AFX) - Medtronic (MDT) has begun the full U.S. rollout of the MiniMed 780G insulin delivery system integrated with Abbott's Instinct sensor, following FDA clearance earlier this year. ...
Medtronic (MDT) Launches MiniMed 780G System with Instinct Sensor in the U.S.
Medtronic (MDT) Launches MiniMed 780G System with Instinct Sensor in the U.S.
Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott
GALWAY, Ireland , Dec. 2, 2025 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated...
3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio
Intuitive Surgical shows why now is a good time to consider buying surgical-robot competitor Medtronic. Eli Lilly helps explain why down-and-out drugmaker Pfizer could be worth a close look for long-t...
Best Dividend Aristocrats For December 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW,...